Medicare Enrolled
Dr. Monali Patel, M.D.
Neurology · San Diego, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Monali Patel is a neurology specialist in San Diego, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 1,426 Medicare services across 822 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $215,792 from 95 pharmaceutical and/or device companies across 1418 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 25% volume in CA
$215,792 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,426
Medicare services
Top 25% in CA for neurology
822
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~84 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
649 | $134 | $225 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
137 | $33 | $130 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
116 | $75 | $387 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
98 | $135 | $425 |
| New patient office visit, complex (60-74 min) | 78 | $175 | $350 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
54 | $98 | $220 |
| Eye photography Photographic imaging of the interior structures of the eye. |
53 | $21 | $85 |
| Abnormal eye movement test with recording A test that records and evaluates eye movements to check for abnormalities. |
51 | $21 | $116 |
| Abnormal eye movement test with recording A test that records eye movements in three different positions to check for abnormalities. |
50 | $24 | $118 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
46 | $73 | $190 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
42 | $113 | $220 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
27 | $36 | $60 |
| Head repositioning exercises for dizziness A series of exercises performed to reposition the head, used to treat dizziness. The procedure is administered on a daily basis. |
25 | $36 | $90 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$215,792
Total received (2018-2024)
Avg $30,827/year across 7 years
Top 4% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
95
Companies
1,418
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$198,838 (92.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,737 (7.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$216 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$10,660
2023
$24,975
2022
$34,820
2021
$38,455
2020
$41,336
2019
$30,690
2018
$34,855
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Neurelis, Inc.
$4,235
ABBVIE INC.
$4,205
UCB, Inc.
$462
Lundbeck LLC
$334
Novartis Pharmaceuticals Corporation
$225
Lilly USA, LLC
$144
Teva Pharmaceuticals USA, Inc.
$93
Neurent Medical Limited
$79
Eisai Inc.
$73
PFIZER INC.
$67
TG Therapeutics, Inc.
$65
SK Life Science, Inc.
$65
Takeda Pharmaceuticals U.S.A., Inc.
$63
GE HEALTHCARE
$53
Amgen Inc.
$52
Biogen, Inc.
$51
MITSUBISHI TANABE PHARMA AMERICA, INC.
$47
Octapharma USA, Inc.
$37
LivaNova USA, Inc.
$35
Neurocrine Biosciences, Inc.
$29
Averitas Pharma Inc.
$29
Abbott Laboratories
$29
Alexion Pharmaceuticals, Inc.
$27
InSightec,Inc
$24
Curonix LLC
$22
Grifols USA, LLC
$19
GENZYME CORPORATION
$19
SCILEX PHARMACEUTICALS INC.
$18
Inspire Medical Systems, Inc.
$17
Alnylam Pharmaceuticals Inc.
$15
Celgene Corporation
$14
Amneal Pharmaceuticals LLC
$13
Top 3 companies account for 83.5% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$50,621
Teva Pharmaceuticals USA, Inc.
$50,276
ABBVIE INC.
$23,123
Biohaven Pharmaceutical Holding Company Ltd.
$16,694
Neurelis, Inc.
$15,577
Biohaven Pharmaceuticals, Inc.
$14,638
AbbVie Inc.
$12,143
Allergan, Inc.
$9,339
PORTOLA PHARMACEUTICALS, LLC
$5,607
UCB, Inc.
$1,361
Novartis Pharmaceuticals Corporation
$1,190
Alexion Pharmaceuticals, Inc.
$969
Amgen Inc.
$960
Lundbeck LLC
$938
LivaNova USA, Inc.
$911
Biogen, Inc.
$897
Adamas Pharmaceuticals, Inc.
$585
Horizon Therapeutics plc
$562
GENZYME CORPORATION
$525
Eisai Inc.
$443
Lilly USA, LLC
$390
CSL Behring
$368
Sunovion Pharmaceuticals Inc.
$358
Boston Scientific Corporation
$358
PFIZER INC.
$355
EISAI INC.
$334
SK Life Science, Inc.
$289
Janssen Pharmaceuticals, Inc
$277
GE HEALTHCARE
$254
Octapharma USA, Inc.
$224
Egalet US Inc
$216
Zyla Life Sciences
$210
Upsher-Smith Laboratories LLC
$208
Neurocrine Biosciences, Inc.
$195
Neurent Medical Limited
$193
SCILEX PHARMACEUTICALS INC.
$193
Avanir Pharmaceuticals, Inc.
$190
Scilex Pharmaceuticals Inc.
$182
PORTOLA PHARMACEUTICALS, INC.
$175
AstraZeneca Pharmaceuticals LP
$174
UPSHER-SMITH LABORATORIES LLC
$152
GE HealthCare
$150
SI-BONE, Inc.
$138
ARBOR PHARMACEUTICALS, INC.
$126
Alcon Vision LLC
$124
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$120
Vanda Pharmaceuticals Inc.
$111
GE Healthcare
$110
Allergan Inc.
$104
MITSUBISHI TANABE PHARMA AMERICA, INC.
$101
ACADIA Pharmaceuticals Inc
$97
Celgene Corporation
$95
Genentech USA, Inc.
$91
JAZZ PHARMACEUTICALS INC.
$89
GRT US Holding, Inc.
$88
Takeda Pharmaceuticals U.S.A., Inc.
$86
TerSera Therapeutics LLC
$78
Banner Life Sciences, LLC
$72
Almatica Pharma LLC
$70
Mallinckrodt Hospital Products Inc.
$70
Acorda Therapeutics, Inc
$67
TG Therapeutics, Inc.
$65
Amneal Pharmaceuticals LLC
$59
Abbott Laboratories
$58
BOSTON SCIENTIFIC CORPORATION
$58
Grifols USA, LLC
$56
Bausch Health US, LLC
$51
Nevro Corp.
$49
Greenwich Biosciences, Inc.
$49
MDD US Operations, LLC
$47
Currax Pharmaceuticals LLC
$46
Promius Pharma LLC
$42
Alnylam Pharmaceuticals Inc.
$41
SANOFI-AVENTIS U.S. LLC
$37
Sumitomo Pharma America, Inc.
$35
AbbVie, Inc.
$34
Xeris Pharmaceuticals, Inc.
$34
Alfasigma USA, Inc.
$31
Medtronic, Inc.
$30
Zyla Life Sciences, Inc.
$30
Averitas Pharma Inc.
$29
ANI Pharmaceuticals, Inc.
$28
BIOTRONIK INC.
$26
InSightec,Inc
$24
Mitsubishi Tanabe Pharma America, Inc.
$23
Curonix LLC
$22
Assertio Therapeutics, Inc.
$21
CATALYST PHARMACEUTICALS, INC.
$19
Inspire Medical Systems, Inc.
$17
TG THERAPEUTICS, INC.
$17
Jazz Pharmaceuticals Inc.
$15
Vertical Pharmaceuticals, LLC
$15
Medtronic USA, Inc.
$15
Pernix Therapeutics Holdings, Inc.
$15
Arbor Pharmaceuticals, Inc.
$13
Top 3 companies account for 57.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Andexxa · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CONTRAVE · COPAXONE · COSENTYX · Clareon · Confirm Rx · DUOPA · Dayvigo · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · Eprontia · Exablate · FABRY-DISEASE · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GENERAL THERAPIES · GENERAL DBS · GENERAL - DBS · GOCOVRI · GRALISE · GVOKE PFS · Gamunex-C · General - Pain Management · Gralise · HETLIOZ · HYQVIA · Hizentra · Horizant · INFINITY · INGREZZA · INSPIRE · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LEQVIO · LYNPARZA · LYRICA · Leqembi · MAYZENT · MIDAS REX · MIGRANAL · NAPRELAN · NAVITOR · NEUROMARK Device · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PANZYGA · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · RADICAVA · RELEXXII · RYTARY · Radicava · SILENOR · SOLIRIS · SPECTRA WAVEWRITER · SPRIX · Senza · Soliris · TEPEZZA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · Xyrem · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZOLGENSMA · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for neurology in CA.
Geographic Context
Neurologists within 10 mi
192
Per 100K population
5.8
County median income
$102,285
Nearest hospital
SHARP MEMORIAL HOSPITAL
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a clinical cardiology specialist, with above-average Medicare volume (top 25% in CA), with speaking/promotional industry engagement in the top 4% of CA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Patel performed 649 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $215,792 from 95 companies across 1,418 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other neurologists in San Diego?
Dr. Patel's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in San Diego
Browse neurologists in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology